A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.

Primary Sponsor

NCIC CTG

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

180

Trial Chairperson

International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua

Trial Contact

ymurray@ctg.queensu.ca

Clinical Trial Registration

Related Post

26 September, 2026

Trial finds radiation therapy halves risk of brain tumour recurrence after surgery

LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery

17 September, 2026

Meet the TROG Quality Assurance team

TROG UPDATES: 17 September 2026 Our Quality Assurance team